ERCC4 Gene Xeroderma pigmentosum group F Genetic Test
At DNA Labs UAE, we offer the ERCC4 Gene Xeroderma pigmentosum group F Genetic Test. This test helps in the diagnosis of Xeroderma pigmentosum, group F (XP-F), a rare genetic disorder.
Test Details
The ERCC4 gene is associated with Xeroderma pigmentosum, group F. This condition affects the ability of cells to repair DNA damage caused by UV radiation from the sun. Individuals with XP-F have a mutation in the ERCC4 gene, which affects the production of the XPF protein responsible for DNA repair.
Components and Price
The ERCC4 Gene Xeroderma pigmentosum group F Genetic Test costs AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results are typically delivered within 3 to 4 weeks.
Method
We use NGS (Next-Generation Sequencing) technology to analyze the DNA sequence of the ERCC4 gene.
Test Type
This test falls under the categories of Osteology, Dermatology, and Immunology Disorders.
Doctor and Test Department
The ERCC4 Gene Xeroderma pigmentosum group F Genetic Test is performed by our Dermatologist and falls under the Genetics department.
Pre Test Information
Before undergoing the ERCC4 Gene Xeroderma pigmentosum group F Genetic Test, it is important to provide the clinical history of the patient. A Genetic Counselling session may also be conducted to draw a pedigree chart of family members affected by ERCC4 Gene Xeroderma pigmentosum, group F.
Test Benefits
The NGS genetic test for the ERCC4 gene helps confirm a diagnosis of XP-F and provides appropriate management and counseling for affected individuals and their families. It can also be used for carrier testing and prenatal diagnosis in families with a history of XP-F.
By choosing DNA Labs UAE for your ERCC4 Gene Xeroderma pigmentosum group F Genetic Test, you can expect accurate results, comprehensive analysis, and professional guidance throughout the process.
| Test Name | ERCC4 Gene Xeroderma pigmentosum group F Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ERCC4 Gene Xeroderma pigmentosum, group F NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC4 Gene Xeroderma pigmentosum, group F NGS Genetic DNA Test gene ERCC4 |
| Test Details |
The ERCC4 gene is associated with a condition called Xeroderma pigmentosum, group F (XP-F). Xeroderma pigmentosum is a rare genetic disorder that affects the ability of cells to repair damage to their DNA caused by ultraviolet (UV) radiation from the sun. Individuals with XP-F have a mutation in the ERCC4 gene, which is responsible for producing a protein called XPF. This protein plays a crucial role in the repair of DNA damage. When the ERCC4 gene is mutated, the XPF protein is either absent or not functioning properly, leading to an impaired DNA repair mechanism. NGS (Next-Generation Sequencing) is a type of genetic test that can be used to analyze the DNA sequence of the ERCC4 gene. This test can identify specific mutations or variations in the gene that are associated with Xeroderma pigmentosum, group F. NGS is a powerful tool that allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of an individual’s genetic makeup. By performing an NGS genetic test for the ERCC4 gene, healthcare professionals can confirm a diagnosis of XP-F and provide appropriate management and counseling for affected individuals and their families. Additionally, this test can be used for carrier testing and prenatal diagnosis in families with a history of XP-F. |
